Great to see TSI advancing the adoption of BFPC.
We are very pleased to see TSI highlighting the collaboration among major pharmaceutical manufacturing businesses to advance the adoption of Biofluorescent Particle Counters (BFPC).
We are very pleased to see TSI highlighting the collaboration among major pharmaceutical manufacturing businesses to advance the adoption of Biofluorescent Particle Counters (BFPC).
We will be exhibiting with our new business partner, Astech, at the Biopharma & Life Sciences Connected Live event on 25th January at the Radisson Blu Hotel in Cork. Mike Dingle, TSI's BioTrak expert, will present a paper on BFPC to show how it is an ideal solution for meeting Annex 1 viable air testing requirements.